Actively Recruiting

Age: 18Years +
All Genders
ID06350968

Implementation of Online Advance Care Planning Tool for (Hemato-)Oncological Patients Within the Cancer Network CONCORD

Led by Erasmus Medical Center · Updated on 2024-04-08

30

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

Sponsors

E

Erasmus Medical Center

Lead Sponsor

M

Maasstad Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating how an online advance care planning module is implemented and used for patients with blood cancers and other cancers within the oncology network CONCORD. The study aims to understand how early integration of advance care planning in cancer care can help discuss patient preferences and improve treatment planning. This mixed-methods research includes both qualitative interviews and quantitative data analysis. The study involves oncology patients treated in hospitals within the CONCORD network during their palliative phase, as well as healthcare providers and implementation staff. Qualitative research gathers experiences through interviews with patients, relatives, medical staff, and project leaders before and after implementation. Quantitative research uses anonymized electronic health record data from patients who have died to analyze the use and outcomes of the advance care planning module. Participants share their experiences with the module while the researchers collect data on medical care and costs in the last three months of life. The study measures how well the module is implemented and its effects over three years. Data includes demographics, healthcare use such as ICU admissions and emergency visits, and economic analysis of care costs. The goal is to improve advance care planning integration in daily oncological care.

CONDITIONS

Brief Title

Implementation of Online Advance Care Planning Tool for (Hemato-)Oncological Patients Within the Cancer Network Concord

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older
  • Diagnosed with cancer
  • Treated at a hospital within the CONCORD oncology network
Not Eligible

You will not qualify if you...

  • None specified

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Long-term Monitoring

Duration - Up to 3 years

Participants who undergo routine care are observed to assess the implementation and use of an online advance care planning tool within the oncology network. Data on medical care in the last three months of life and advance care plans are collected and analyzed.

Trial Site Locations

Total: 1 location

1

Joica Benschop

Rotterdam, Netherlands, 3023TB

Actively Recruiting

Loading map...

Research Team

J

Joica A.M. Benschop, MSc

E

Erasmus Medical Center Oldenmenger, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Two Single Arm, Multicentre Unblinded Trials Investigating a...

Catheter Blockage

Actively Recruiting

2 locations

A Phase 1/2 Study of BIO-106 Alone or With Pembrolizumab in ...

Advanced Cancer

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here